Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The Republican urge to cut funding is not necessarily anti-science, and the research community ought not to pick political sides, says Daniel Sarewitz.
The anxiety and stigma associated with Ebola are hampering Australia's willingness and ability to help with the control efforts in Africa, argues Tim Inglis.
Better collaboration is a laudable goal, but that alone will not be enough to fix the damage caused by Europe’s falling investment, says Amaya Moro-Martin.
Bottlenecks in testing samples for Ebola leave patients stranded for days in isolation wards and raise fears of seeking treatment, says J. Daniel Kelly.